XGEN Venture is an Italian alternative investment fund manager (Società di Gestione del Risparmio, or SGR) established in 2021 by the former Genextra team, with over 15 years of activity and significant experience in the startup process, the discovery and the development of novel solutions for high unmet medical needs. The XGEN team is currently investing out of its first fund, XGEN Venture Life Science Fund launched at the end of 2022, while it continues to advise Genextra’s board of directors on the management of its portfolio.